Annovis made significant progress by advancing the buntanetap program, successfully completing two clinical trials-Phase 2/3 ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...

Researchers from the Liverpool School of Tropical Medicine (LSTM) and the Kenya Medical Research Institute (KEMRI) Wellcome ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.